T. Rowe Price Associates
CALA

T. Rowe Price Associates’s Calithera Biosciences, Inc CALA Stock Holding History

T. Rowe Price Associates’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,047
Closed -$196K – 2967
2021
Q1 		$196K Buy
4,047
+1,250
+45% +$72.8K ﹤0.01% 2696
2020
Q4 		$275K Sell
2,797
-585
-17% -$51.3K ﹤0.01% 2457
2020
Q3 		$233K Hold
3,382
– – ﹤0.01% 2379
2020
Q2 		$357K Sell
3,382
-1,388
-29% -$165K ﹤0.01% 2189
2020
Q1 		$424K Buy
4,770
+121
+3% +$14.4K ﹤0.01% 2056
2019
Q4 		$531K Buy
4,649
+1,524
+49% +$115K ﹤0.01% 2131
2019
Q3 		$193K Buy
3,125
+309
+11% +$24.7K ﹤0.01% 2388
2019
Q2 		$220K Buy
2,816
+5
+0.2% +$567 ﹤0.01% 2391
2019
Q1 		$379K Buy
2,811
+5
+0.2% +$525 ﹤0.01% 2218
2018
Q4 		$225K Buy
2,806
+258
+10% +$25.4K ﹤0.01% 2380
2018
Q3 		$268K Sell
2,548
-739
-22% -$70.4K ﹤0.01% 2395
2018
Q2 		$329K Buy
3,287
+215
+7% +$24.4K ﹤0.01% 2321
2018
Q1 		$387K Buy
3,072
+643
+26% +$100K ﹤0.01% 2184
2017
Q4 		$406K Buy
+2,429
New +$622K ﹤0.01% 2173
2015
Q4 		– Sell
-863
Closed -$94K – 2551
2015
Q3 		$94K Buy
863
+28
+3% +$3.63K ﹤0.01% 2416
2015
Q2 		$119K Sell
835
-61,228
-99% -$14.2M ﹤0.01% 2433
2015
Q1 		$20.4M Sell
62,063
-1,380
-2% -$491K ﹤0.01% 1129
2014
Q4 		$24.9M Buy
+63,443
New +$16.6M 0.01% 1060

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates's CALA Position: Q2 2021 in Review

T. Rowe Price Associates sold out of Calithera Biosciences, Inc (CALA) in Q2 2021, closing a stake of 4,047 shares — an estimated $196K sold.

T. Rowe Price Associates first reported a position in CALA in Q4 2014 and held it in 18 quarters. The position peaked at $24.9M in Q4 2014. 76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

  • T. Rowe Price Associates reported no remaining Calithera Biosciences, Inc position as of Q2 2021 after selling out during the quarter.
  • T. Rowe Price Associates sold 4,047 Calithera Biosciences, Inc shares in Q2 2021, an estimated $196K.
  • T. Rowe Price Associates first reported a position in Calithera Biosciences, Inc in Q4 2014 and held it in 18 quarters.
  • T. Rowe Price Associates's Calithera Biosciences, Inc position peaked at $24.9M in Q4 2014.
  • 76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.